Why clinical trials are leaving the US—and Asia and Australia are welcoming them

Disruption and uncertainty in the US are leading many clinical trials to consider other countries for participation. <b>Jennifer Lutz</b>, <b>Neha Bhatt</b>, and <b>Flynn Murphy</b> report on the changing landscape—and why some places are making a major play for trials fleeing the US

Authors

Publication Details

Journal
BMJ
Published
2026-02-13
DOI
https://doi.org/10.1136/bmj.s220
Citations
1
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
41.85
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Why clinical trials are leaving the US—and Asia and Australia are welcoming them

Jennifer Lutz, Flynn Murphy, Neha Bhatt
1 citations
BMJ
Ethics in Clinical Research
41.85
article

Why clinical trials are leaving the US—and Asia and Australia are welcoming them

Jennifer Lutz, Flynn Murphy, Neha Bhatt
article en
1 citations

Abstract

Disruption and uncertainty in the US are leading many clinical trials to consider other countries for participation. <b>Jennifer Lutz</b>, <b>Neha Bhatt</b>, and <b>Flynn Murphy</b> report on the changing landscape—and why some places are making a major play for trials fleeing the US

BMJVol. 392
Openalex Percentile: Top 1%
Ethics in Clinical Research
41.85
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Why clinical trials are leaving the US—and Asia and Australia are welcoming them — Jennifer Lutz, Flynn Murphy, et al. · BMJ (2026) | TGRS Research Map | TGRS